In summary, our study demonstrates that the ES-specific transcription factor ZFP57 is a tumour suppressor factor in breast cancer and targets oncogenic MEST directly through regulating the methylation of the MEST promoter region and subsequently suppressing the Wnt/β-catenin pathway. Here, MEST is linked to breast cancer.